Overview
Lipids are some of the most clinically important excipients for drug delivery systems and are especially relevant for RNA-based therapies and mRNA vaccines. As a CDMO partner offering end-to-end solutions, Evonik has decades of experience and expertise in every step of the manufacturing process, including route scouting, process development and optimization, purification, isolation, characterization, scale-up, and commercialization.
This workshop will focus on the growth and use of lipids for drug delivery and provide insight into important steps for success. We will not only outline the role of our novel multivariate models to speed up timelines and increase successful scale-up and transfer to the clinic, but also highlight current advances in leveraging novel lipids, such as randomized PEGs (rPEGs) in LNP-based delivery systems.
Key learnings for participants
- Introduction to capabilities necessary to support lipid development and manufacturing
- Lipid impurities and their impact on therapeutic effectiveness
- LNP formulation opportunities with rPEGs
This event will be jointly hosted by Evonik Health Care and Knauer. We are delighted to welcome our esteemed speakers from Evonik and Knauer, as well as leaders from industry and academia, who will present exciting insights and case studies.
Agenda
Senior Scientist RD&I
Evonik Health Care
Janis Fiedler
Knauer
Director of Formulation and Process Development
Evonik Health Care
02:00 p.m. | Wrap-up